z-logo
open-access-imgOpen Access
Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy
Author(s) -
Sidonie Lambert-Niclot,
Philippe Flandre,
M. A. Valantin,
Gilles Peytavin,
Sophie Sayon,
Laurence MorandJoubert,
Constance Delaugerre,
M. Algarte-Genin,
Christine Katlama,
Vincent Cálvez,
AnneGeneviève Marcelin
Publication year - 2012
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dks052
Subject(s) - darunavir , ritonavir , virology , medicine , viral load , drug resistance , oncology , biology , virus , genetics , antiretroviral therapy
To analyse the emergence of resistant viruses in patients failing darunavir monotherapy, including minority species, and to investigate the impact of baseline reverse transcriptase (RT), protease (PR) and gag resistance mutations on virological failure (VF) occurrence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom